The bihormonal fully closed loop solution
The Inreda AP® is Inreda’s solution for improving diabetes care. Discover the bi-hormonal artificial pancreas: a fully closed-loop system that automatically regulates glucose levels using both insulin and glucagon.
Features
The Inreda AP® fully regulates the administration of glucagon and insulin automatically. No user input is required, making carbohydrate counting and meal announcements a thing of the past.
To balance blood glucose levels, the Inreda AP® uses two
hormones: glucagon and insulin. Glucagon is used to raise the blood glucose level and insulin is used to lower it.
No bolus, no basal
No meal & excercise announcements

How does the AP® work?
The sensors measure glucose levels
The Inreda AP® uses two sensors to simultaneously measure
blood glucose levels. This ensures safe treatment based on continuously validated measurements. Glucose values are sent wirelessly to the Inreda AP® and used as input for the algorithm.
Self-learning algorithm
The Inreda AP® algorithm continuously responds to changes in blood glucose levels and automatically delivers doses as soon as a change is detected.
Up & down
Additionally, the algorithm continuously adapts to optimize and personalize glucose control.
The Inreda AP® improves the regulation in adults with type 1 diabetes after 1 year of use.1
- More than 25 minutes per day less in hypoglycaemic values (<3,9 mmol/L) compared to the previous treatment;
- A 0,9% decrease in HbA1c compared to the previous treatment;
- More than 97% of the Inreda AP® users achieve
the recommended combined treatment goal of
70% time in range and <4% time below range; - Inreda AP® users experience a decrease in diabetes distress compared to the previous treatment.



